In December 2016 Harbour Antibodies was acquired by Harbour BioMed, a Shanghai-based company, to develop next-generation therapeutic antibodies for cancer.
Harbour BioMed Acquires Harbour Antibodies to Create Global, Oncology-focused Biotechnology Company
Location: United States, Massachusetts, Cambridge
Member count: 11-50
Total raised: $3.31106M
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Atlas Vent... | atlasventu... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 25.07.2013 | - | $3.31106M | - | finsmes.co... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 25.07.2013 | Harbour An... | Harbour Antibodies BV, a Rotte... | funding N... | - | finsmes.co... |